Literature DB >> 6855012

Macular involvement in morning glory syndrome.

T Yamana, M Nishimura, K Ueda, T Chijiiwa.   

Abstract

Clinical features of morning glory syndrome were studied in 8 eyes of 7 patients. The cases were divided into two groups according to the size of the elevated peripapillary white ring. The size of the ring was expressed as an average disk diameter of normal control eyes. In 2 eyes of Group I with the ring less than 2.0 disk diameters, white tissue on the disk was less pronounced than in Group II, and vascular pattern in the posterior retina was almost normal. The macular ring reflex was present. In 6 eyes of Group II with the ring exceeding 2.0 disk diameters, white tissue on the disk was more marked than in Group I, and retinal vessels were narrow and extended straight toward the midperiphery. the macula was not formed, but a yellowish retinal area was observed on the center or temporal part of the elevated peripapillary white ring. It was concluded that in morning glory syndrome the macula may often by involved when anomaly of the optic disk is remarkable.

Entities:  

Mesh:

Year:  1983        PMID: 6855012

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

1.  Vitrectomy of rhegmatogenous retinal detachment in morning glory syndrome.

Authors:  Xiao-Li Yang; Xi Zhang
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

2.  Communication between the subretinal space and the vitreous cavity in the morning glory syndrome.

Authors:  G E Coll; S Chang; T E Flynn; G C Brown
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

3.  Morning glory syndrome associated with marked persistent hyperplastic primary vitreous and lens colobomas.

Authors:  G Cennamo; G Liguori; A Pezone; G Iaccarino
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

4.  Morning glory syndrome: clinical and electrofunctional study of three cases.

Authors:  G Giuffrè
Journal:  Br J Ophthalmol       Date:  1986-03       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.